HOME >> BIOLOGY >> NEWS
Anti-inflammatory drugs interact with HRT, and more

ndings will need to be addressed in future trials.

Citation: Garcia Rodrıguez LA, Egan K, FitzGerald GA (2007) Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: A drugdrug interaction" PLoS Med 4(5): e157. doi:10.1371/journal.pmed.0040157

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040157

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-05-fitzgerald.pdf

CONTACT:
Dr. Garret A FitzGerald
University of Pennsylvania
Institute for Translational Medicine and Therapeutics
153 Johnson Pavilion
3620 Hamilton Walk
Philadelphia, PA 19104-6084
United States of America
+1 215 898-1185
+1 215 573-9135 (fax)
garret@spirit.gcrc.upenn.edu


Understanding the Slow Depletion of Memory CD4+ T Cells in HIV Infection

Using a simple mathematical model, Andrew Yates and colleagues show that a runaway cycle of T cell activation and infection cannot explain the slow rate of CD4 decline during chronic HIV infection. A related perspective by Rob de Boer discusses the study

Citation: Yates A, Stark J, Klein N, Antia R, Callard R (2007) Understanding the slow depletion of memory CD4 T cells in HIV infection. PLoS Med 4(5): e177. doi:10.1371/journal.pmed.0040177

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pme
'"/>


Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
21-May-2007


Page: 1 2 3 4 5

Related biology news :

1. Anti-inflammatory effects of omega 3 fatty acid in fish oil linked to lowering of prostaglandin
2. MIT model could predict cells response to drugs
3. New target for HIV/AIDS drugs and vaccine discovered
4. Modified mushrooms may yield human drugs
5. UGR researchers design an alternative to blood test to detect drugs in the body
6. Could fungal collection hold the key to new life-saving drugs?
7. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
8. Scientists develop new drugs to fight colon and breast cancer more effectively
9. Generic biologic drugs unlikely to offer significant savings
10. Stem cells provide new tool for studying disease and identifying ALS drugs
11. Enhancing chemotherapys efficacy: New agent has synergistic effect with standard drugs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anti inflammatory drugs interact with HRT and more

(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/26/2015)... ... August 26, 2015 , ... Lee ... in the development and manufacture of highly valued cardiac markers used in early ... extensive expertise with protein chemistry has led to the development and commercialization of ...
(Date:8/26/2015)... GERMANTOWN, Md. , Aug. 26, 2015 ... synthetic biology, announced today the closing of its previously ... in full by the underwriters of their option to ... the public offering price of $41.00 per share.  The ... of shares of common stock sold by Intrexon to ...
(Date:8/26/2015)... , August 26, 2015 After litigating ... Europlasma NV relating to P2i United States ... their dispute in the United States ... the part of either party. As a result of the ... of California dismissed the case without ...
(Date:8/26/2015)... ... 2015 , ... The 2015 Epigenomics & Metabolomics Meeting in Boston ... Asymmetrex to share the first report on progress with its crowdsourcing campaign designed ... tissue stem cells. , With a name like “H2A.Z asymmetry,” the new biomarker would ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4P2i Settles United States Litigation 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 4
Cached News: